Reckitt Benckiser has handed its first advisory mandate to Goldman Sachs, less than 18 months after the bank managed the $3.4bn (€2.6bn) sale of Boots Healthcare International to the UK cleaning products company.
Reckitt said in a statement it has appointed Goldman Sachs to conduct a strategic review of the Hermal prescription healthcare business it acquired as part of Boots Healthcare International's portfolio in July 2005.